.....that with 70% of the shares gobbled up by Institutions, there aren't too many individual investors here. But, if there is anyone new here and are wondering how to learn more about Insmed's Arikace......go to the Insmed website and click your way to the "Investor Presentation". It's a fun read. It's also good information for reinforcement for many of us. I'm sure all of the institutions invested in Insmed know all about this information. Otherwise, they wouldn't be here.
I think the more important number is the 71% regardless of the number of shares. Do you happen to know what the percentage was in July? I seem to recall that the percentage was around 41% for some time. Anyway, I think the comparison of percentages would be interesting.
71% reported held by Institutions.
Total Shares Held: 105 27,648,992
New Positions: 31 4,366,683
Increased Positions: 66 13,199,821
Decreased Positions: 29 1,929,443
Holders With Activity: 95 15,129,264
Sold Out Positions: 12 613,672
NASDQ shows 71.......CNBC shows 77 (although doughcm says 80). My question is......are these institutions going to be happy with the games here......OR.........??????
Does anyone know when Quaker purchased 2.9 million or when Bessemer bought in for around 770,000 shares? They show up on the cnbc site but not the NASDQ site yet (which will update in a few days for the 3rd quarter).
Hi back, Bo. I, also, wouldn't mind Insmed being in the position of "licensee". Shoot, I have always been a proponent of the opt-in scenario by Ipsen and/or Roche.
So, was that an apology? (LOL)
On another note.....could there be an opportunity here for Insmed to revisit their Duchennes DMD trials? Wouldn't that tick AF off?? (LOL)
Perhaps he is just trying to get people to let go their shares so the institutions can buy more. Someone posted today that the institutional holdings is now over 60%
Sorry.....I try not to give silly advice like that. If you are going to buy-in long, I don't want to be responsible for you losing money if the price goes down. If you are going to buy-in short, I don't want you to make any money doing that. With that said, it appears that Institutional holding has gone from about 45% last quarter to a current figure of approximately 55% according to the CNBC site.
.....October 31 was the last settlement date for short interest. Tomorrow is when that information is disseminated. Question.....will it show a share increase or a share decrease?
Well, reaching for the stars.....let me be a "dreamer". I would be happy with selling iPlex for $180.00/share. Then sell Arikace for $180.00/share. That should give Insmed enough money to develop INSM-18
Oops....sorry for my misreading. We will just have to disagree here.....hopefully cordially (LOL). While we are blessed with what we have in Arikace and I look forward to seeing how this story plays out.....I am still here.....patiently waiting..... for the rest of the iPlex story.